Webinar on

Neurology and Alzheimer’s Disease

September 23-24, 2024

Theme – Neurological Insights into Alzheimer’s Disease: Challenges & Breakthroughs

Organizing Committee

Check out our OCM

Submit Abstract

Submit Research Article

Registration

Few Speaker Slots are Available

Download Brochure Now

About Neurology & Alzheimer’s Disease

Join us at the Webinar on Neurology and Alzheimer’s Disease” scheduled to be held on September 23-24, 2024, Themed “Neurological Insights into Alzheimer’s Disease: Challenges & Breakthroughs”. This global platform welcomes all the researchers, professors, clinicians, and professionals in and around related to fields of neurology, neuroscience, alzheimer’s and dementia. Be a part of this webinar to explore current issues, share research, and connect with experts in neurology and many more. 

Speakers

Brandon Lucke-Wold

University of Florida, USA

Austen Milnerwood,

McGill University, Canada

George R.

University of Maryland, Maryland

Scientific Sessions

01.Neurology

02. Advancements in Neurology

03. Alzheimer’s and Parkinsons Diseases

04. Biology of Aging and Neurogenesis

05. Brain Injury and Behavioural Neuroscience

06. Brain Pathology and Oncology Research

07. Brain Stimulation and Imaging

08. Brain Structure and Function

Who to attend Neurology Webinars?

Why to attend Neurology Webinars?

Neurology 2024 Webinar will bring together experts like neurologists, neuroscientists, clinicians, neurogeneticst, psychiatrists, medical practitioners, care specialists, academic professionals, and students from all over the world to share an interest in the genetic pathways underlying neurological disorders, techniques to identify those genetic pathways, and the use of genetics and genomics as tools to develop therapeutics. 

The aim of the conference is to provide a platform to academicians and practitioners from multiple disciplines to debate and deliberate on social change that is encompassed by innovation and technology. 

Media Partners & Collaborations

Event Summary

Join our upcoming webinar for a comprehensive exploration of cutting-edge developments. Engage with top experts in the field, network with peers worldwide, and gain invaluable insights into the latest trends and tactics. We’ve extended invitations to globally renowned keynote speakers, experts, brand ambassadors, and industry leaders, who will graciously share their insights and ideas with our esteemed webinar attendees.

Don’t miss this opportunity to expand your knowledge and stay ahead of the curve. Register now to secure your spot!”

The webinar is entirely virtual and accessible from anywhere with an internet connection. Specific dates and times for the event are provided on the webinar website.

Abstract submission guidelines and deadlines will be provided on the webinar website. Please refer to these guidelines when preparing and submitting your abstract for consideration.

Each Keynote Presenter will have 30-45 minutes, while Oral Presenter will have 20-25 minutes for presentation including Q/A session.

Each Poster Presenter will have 10-15 minutes for presentation including Q/A.

All presenters are requested to present their paper only in English.

We do not provide any translators during presentations. However, you can hire your own translator for the presentation.

Registration details, including instructions and fees (if applicable), will be available on the webinar website.

For further assistance or inquiries regarding the webinar, please contact our webinar organizers at [support@stripewebinars.com or +1 424 382 0198]. We’re here to help!

Contact Us

If you ever need assistance or have questions, please don’t hesitate to reach out to our dedicated support team.
Call Back Request

WhatsApp Now

We use essential cookies to make our site work. With your consent, we may also use non-essential cookies to improve user experience and analyze website traffic. By clicking “Accept,” you agree to our website's cookie use as described in our Cookie Policy. You can change your cookie settings at any time by clicking “Preferences.”

Brandon Lucke-Wold

University of Florida, USA

Brandon Lucke-Wold was born and raised in Colorado Springs, CO. He graduated magna cum laude with a BS in Neuroscience and distinction in honors from Baylor University. He completed his MD/PhD, Master’s in Clinical and Translational Research, and the Global Health Track at West Virginia University School of Medicine. His research focus was on traumatic brain injury, neurosurgical simulation, and stroke. At West Virginia University, he also served as a health coach for the Diabetes Prevention and Management program in Morgantown and Charleston, WV, which significantly improved health outcomes for participants. In addition to his research and public health projects, he is a co-founder of the biotechnology company SwiftScience, the pharmaceutical company ProPhos Neuroscience, and was a science advocate on Capitol Hill through the Washington Fellow’s program.

He has also served as president of the WVU chapters for the American Association of Pharmaceutical Scientists, Neurosurgery Interest group, and Erlenmeyer Initiative Entrepreneur group. In addition, he has served as vice president for the graduate student neuroscience interest group, Nu Rho Psi Honor Society, and medical students for global health. He was an active member of the Gold Humanism Honor Society and Alpha Omega Alpha Honor Society. He is currently Vice President of the UF House Staff Council, Chair of the Quality Improvement Committee, on the Board of Directors for the Alachua County Medical Society, and active member of Institutional Review Committee and Accreditation Requirements Review Committee. He is married to Noelle Lucke-Wold and has two children. As a family, they enjoy running with their dogs, rock climbing, and traveling. In his spare time, Brandon frequently runs half marathons and 10ks together with is wife. Brandon also enjoys reading, playing piano, discussing philosophy, and playing chess. He is currently a Pgy6 neurosurgery resident at University of Florida with pursuing endovascular enfolded training and was awarded the Dempsey Cerebrovascular Research Fellowship, SNS Fellowship, Van Wagenen Fellowship, R25 Grant, and SNIS Fellowship.

Austen Milnerwood

McGill University, Canada

Austen Milnerwood’s research centers on cell biological, electrophysiological and optical investigation of neural development, connectivity, transmission and plasticity. With a major focus on the early pathophysiology of adult-onset diseases such as movement disorders and dementia, his laboratory aims to develop neuroprotective treatments. Our projects include behavioural studies in rodents, electrophysiology and cell biology in acute brain slices, primary neuronal co-cultures and patient stem cell-derived neuron models.

A strong theme has emerged from studying several proteins harbouring mutations that are autosomal dominantly linked to Parkinson’s disease, in other words, genes transmitted down the family line that are highly predictive for developing PD. There are several proteins that cause “familial PD,” e.g. LRRK2, VPS35 and synuclein. Milnerwood’s laboratory is finding that these proteins are involved in the same cellular functions. By learning more about what these proteins are supposed to do and what goes wrong with the mutations present, Milnerwood hopes to work out the common neuronal dysfunction of many forms of parkinsonism and then develop appropriate treatments.

Working out how neuronal function goes awry early in disease states can help to intervene and possibly to prevent the onset or progression of degenerative processes. The world’s population is aging. By 2025, half of the population may be over 60 years old, and up to 2% might have Alzheimer’s or Parkinson’s disease. There is a pressing societal and financial need to learn more about, and to better treat, human neurodegenerative disease.

George R.

University of Maryland, Maryland

Assistant Professor (Johns Hopkins, Massachusetts General Hospital/Harvard Medical School, Neuorlogy and Neuroscience)

Associate Investigator HHMI

Associate Professor (part time) Johns Hopkins (Neurology and Neuroscience)

Branch Chief and Acting Scientific Director NIH (NIDA)

Professor (part time then adjunct) Johns Hopkins School of Medicine, Johns Hopkins School of Putlic Health (Neurology, Neuroscience, Mental Health), University of New Mexico (Neurology, Neuroscience, Molecular Biology and Genetics)

Neurologist, Chief of Neurology, Associate Chief of Staff for Research (New Mexico VA Healthcare System, VA Maryland Healthcare System) 

Professor, University of Maryland School of Medicine (Neurology, Pharmacology)